Dr Ahmed Ogwell Ouma, Africa CDC’s outgoing acting deputy director general, confirms that he is leaving Africa CDC – won’t take a post in another African Union institution.

Acting director of the Africa CDC, Dr Ahmed Ogwell Ouma, on Thursday confirmed that he is leaving the agency at the end of the month. He denied, however, earlier reports that his departure was tied to African CDC age or geographic restrictions in the recruitment of a permanent candidate, but rather attributed the decision to “personal reasons”.

“It has not been an easy decision considering my love and commitment to Africa, but the time has come for me to pursue my professional and personal growth elsewhere. I also confirm that my decision is not in any way related to, nor motivated by any of the ongoing recruitment processes within Africa CDC or the African Union,” Ouma stated in a post on LinkedIn.

The official AU announcement for the position in September 2023 encouraged candidates from “less represented countries within the African Union” – although it did not specifically exclude Kenyans.

But in an X post in December, the CDC’s new director general, A Jean Kaseya made it even more explicit. He said the “ideal candidate” for the deputy director general position should be “under the age of 55” years and from one of the AU’s 32 under-represented countries – effectively excluding Ouma on two counts. 

Kaseya, when he assumed the post of Africa CDC director general following his February 2023 election by AU heads of state, said that he wants Africa CDC to reflect the continent’s diversity. Effectively, however, the recruitment conditions Kaseya cited also clear the table of previous leadership that could challenge Kaseya politically and institutionally in his new role.  In the year prior to Kaseya taking office, Ouma was acting director of Africa CDC.

Ouma’s departure from Africa CDC described as a big loss by some

Ouma described his experience at Africa CDC as one of “honour and privilege to serve my continent Africa,” he said in his LinkedIn post. “I have served with passionate professionals, learnt from seasoned leaders, energised by the vigour of African youth, and blessed with the wisdom of African elders. I have also had the privilege of working with partners (I call them Friends of Africa!) as they supported our work and contributed to our vision of a New Public Health Order.” 

The announcement was met with accolades for Ouma – and some predictions that the departure of the veteran health official is not only a loss, but an institutional setback, as the agency tries to establish itself as an autonomous continental health agency.

David Adetula, Co-Founder and Executive Director, Public Health Interest Group Africa (PHIGA), described Ouma as “a huge inspiration to me, and millions of young Africans who are passionate about fixing the continent’s health systems. Your contribution, to bringing youths to the table, stands tall.”

Ouma’s legacy at Africa CDC

Ouma led the continent through the final stages of the COVID pandemic as well as the 2022 global mpox health emergency.  In both episodes he quickly made a name for himself, asserting a strong role for the Africa health agency.

He argued with WHO over the right of Africa CDC to  declare continental health emergencies – in cases where WHO’s own legal powers relate solely to global health emergency declarations. Ouma also demanded more mpox diagnostics and vaccine allocations for Africa – where the disease is endemic but medical tools to prevent and treat it remain largely unavailable.

Dr Ahmed Ogwell Ouma at press briefing in June 2022 as Africa CDC’s acting director asserts the continent should be top priority for vaccine doses for monkeypox.

Kaseya acknowledged Ouma’s remarkable tenure at the Africa CDC, stating that he was instrumental in navigating the center “through unprecedented times”, including the COVID-19 pandemic. Kaseya also recognized Ouma’s  critical role in laying the groundwork for the AU decision in February 2022 to elevate Africa CDC’s status from a technical arm of the AU to an autonomous public health agency.

Ouma, joined Africa CDC in September 2019 as deputy director, a position he held till May 2022 when he became the acting director following the departure of John Nkengasong for a job in the United States as head of PEPFAR, the US President’s Emergency Plan for AIDS relief. Nkengasong built the agency from an AU department into a quasi-autonomous entity, a pathway that Ouma continued in his year-long tenure.

After Kaseya, a Congolese national, took on the post as Africa CDC’s director in mid-2023, Ouma then became acting deputy director once again.  Prior to arriving at Africa CDC, Ouma held several leadership positions in the World Health Organization, including as a senior advisor to WHO’s Director General on non-communicable diseases

Last week, Ogwell was at Harvard completing a Rockefeller Foundation seminar on “executive leadership”.

Reflecting and looking ahead

Speaking to Health Policy Watch on the sidelines of the recently held third International Conference on Public Health in Africa (CPHIA 2023), Ouma expressed pride in the current status of Africa CDC, noting its evolution into a globally trusted leader in pandemic response. 

He also highlighted the institution’s growth from humble beginnings to its central role in leading public health responses on the continent, while also spearheading partnerships and initiatives such as Saving Lives and Livelihoods partnership between Africa CDC and the Mastercard Foundaiton which sought to scale up COVID vaccination on the continent, and lay the groundwork for local vaccine manufacturing.

Ouma emphasized the importance of building and maintaining public health capacity on the continent, with the Africa CDC facilitating coordination and networking among African countries. He noted progress in establishing Public Health Emergency Operation Centers at the country level to ensure real-time information access, laboratory readiness, and expert deployment. Ouma stressed the need to reinforce these efforts to enhance Africa’s preparedness for future outbreaks.

“Africa CDC’s role is to ensure that countries are networked. Having a public health emergency operation center is a sure way for countries to maintain the infrastructure developed at Africa CDC,” Ouma told Health Policy Watch.

Looking ahead, Ouma stated that Africa CDC’s experiences during the pandemic provide valuable lessons for future interventions. He emphasized the organization’s aim to continue building resilience, prioritizing local needs, and selecting appropriate implementing partners to strengthen health security in Africa.

He also emphasized the importance of not waiting for everything to be in place before taking action.  

“Don’t wait for everything to be in place before you act. When you want to save lives, you start saving lives with what you have, and you fix it as you go along,” he said.

Image Credits: Paul Adepoju.

HPV vaccine
The WHO set an ambitious goal of having 90% of girls vaccinated against HPV by 2030

Eliminating cervical cancer is within reach, thanks to new commitments by governments, donors and other partners, including pledges of almost $600 million, made at the first-ever global forum on cervical cancer in Cartagena de Indias in Colombia.

Every two minutes, a woman dies from cervical cancer, although vaccination against human papillomavirus (HPV), the leading cause of cervical cancer, can prevent the vast majority of cases. 

Cervical cancer is the fourth most common cancer in women worldwide, but disproportionately affects women and their families in low and middle-income countries (LMICs). 

Less than 5% of women in many LMICs are ever screened for cervical cancer, and over 90% of the 348 000 cervical cancer deaths in 2022 took place in LMICs. 

Furthermore, only one in five adolescent girls were vaccinated against HPV in 2022. 

Country commitments

global cervical cancer mortality heat map
Low and middle income countries experience the highest burden of cervical cancer

However, a number of countries stepped up at the forum. These include the Democratic Republic of Congo (DRC), which has committed to introduce the HPV vaccine as early as possible, targeting girls aged 9 to 14 years.

Ethiopia aims to reach at least 95% of all 14-year-old girls with the HPV vaccine this year, and screen one million eligible women every year for cervical cancer and to treat 90% of those screened who present with positive precancerous lesions. 

Further, HPV single dose has been approved to be introduced this year and scaled up as part of the country’s Expanded Program on Immunization plans.

Africa’s most populous country, Nigeria, has committed to vaccinating 80% of girls 9 to 14 years old by 2026, including those who are no longer at school.

The nearly $600 million in new funding includes $180 million from the Bill and Melinda Gates Foundation, $10 million from UNICEF, and $400 million from the World Bank. 

Elimination of a cancer

Press conference at the global cervical cancer elimination forum
Experts gathered in Colombia to discuss global collaboration for cervical cancer elimination

“If these ambitions to expand vaccine coverage and strengthen screening and treatment programs are fully realized, the world could eliminate a cancer for the first time,” according to the World Health Organization (WHO).

In 2022, the WHO revised its HPV vaccination recommendation from two to one-dose of the HPV vaccine, making it much easier and cheaper for countries to reach those who need it.

The WHO Americas region made a similar recommendation 2023, and WHO’s African regional just followed suit with its own recommendation

“We have the knowledge and the tools to make cervical cancer history, but vaccination, screening and treatment programmes are still not reaching the scale required,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. 

“This first global forum is an important opportunity for governments and partners to invest in the global elimination strategy and addressing the inequities that deny women and girls access to the life-saving tools they need.” 

However, many LMICs face an uphill battle. Malawian Minister of Health Kandodo Chiponda described the challenges her country faces at the forum’s opening plenary. 

Some 60% of Malawi’s population of over 20 million is under 35, and cervical cancer is the highest cancer burden, with the incidence rate as high as 70 per 100,000. Mortality figures are 52 per 100,000, said Chiponda, who also announced the opening of the first ever cancer center in Malawi. 

Chiponda noted that women have limited time and resources to seek care, limited access to screening and diagnostic services, and are subject to misinformation about vaccinations. 

She emphasized the need for cross-sector collaborations and the strengthening of primary healthcare to reach women and girls in remote areas.

‘Miracle of modern medicine’

WHO director general
“Cervical cancer is a disease of inequity” – Dr. Tedros Adhanom Ghebreyesus, WHO Director-General

“The HPV vaccine is one of the most impactful vaccines on the planet and has already helped save thousands of lives,” said Aurélia Nguyen, Gavi’s chief programme officer. 

Despite the efficiency and safety of the HPV vaccine, high costs, supply chain issues, and difficulties in reaching remote populations keep the vaccine out of reach for many.

“More girls urgently deserve the same protection, which is why in partnership with countries, Gavi has set an ambitious goal to help vaccinate 86 million adolescent girls by 2025. With bold commitment and decisive action, we can look forward to a future where cervical cancer has been eliminated for good.” 

Describing HPV vaccines as “a miracle of modern medicine”, Dr Chris Elias, the Bill and Melinda Gates Foundation’s president of global development, said that there is “no reason why women should die from cervical cancer.”

“Now is the time for governments and partners around the world to increase HPV vaccine access and protect future generations from cervical cancer.” 

Image Credits: Unsplash, IARC/WHO, Global Cervical Cancer Elimination Forum, GCCEF/WHO.

WHO surveys destruction around northern Gaza hospitals last week, in one of the first relief missions to reach the area in over a month.

A United Nations report released Monday said there are “reasonable grounds” to believe that multiple incidents of sexual violence, including rape and gang rape of Israeli women, occurred during the Hamas-led incursion into some 22 Israeli communities near the Gaza border on 7 October. More than 1,200 people were killed in the incident, mostly civilians. 

Meanwhile, Dr Tedros Adhanom Ghebreyesus described “grim findings” of severe malnutrition and  “children dying of starvation” during the first World Health Organization visit to a children’s hospital in northern Gaza since October 2023. He appealed to Israel to permit more regular deliveries of humanitarian aid to the area, still cordoned off by Israeli troops to supply routes from the south.   

“Kamal Adwan Hospital is the only paediatrics hospital in the north of Gaza, and is overwhelmed with patients. The lack of food resulted in the deaths of 10 children. The lack of electricity poses a serious threat to patient care, especially in critical areas like the intensive care unit and the neonatal unit,” Tedros said in a statement posted on X

“We managed to deliver 9,500 litres of fuel to each hospital, and some essential medical supplies. This is a fraction of the urgent lifesaving needs,” said Tedros, referring to a parallel relief mission to Al Awda hospital in northern Gaza’s Jabalya neighbourhood.

“We appeal to Israel to ensure humanitarian aid can be delivered safely and regularly,” Tedros said. 

In just the past several days, WHO teams also managed to access northern Al Shifa hospital, the biggest health facility in the Gazan enclave, for the first time in over a month, delivering 19,000 litres of fuel and treatments for 50 children suffering from acute malnutrition.  

“The level of destruction around the hospital is beyond words. Ceasefire,” Tedros said in another statement.

“Hospitals in Gaza continue to face severe disruptions in providing health care,” reported the UN Office for Coordination of Humanitarian Affairs (OCHA) on Tuesday.

In most incidents, Israeli victims were raped, then killed

Aerial view of one of the sites of the October 7, 2023 assault by Hamas gunmen on the Nova music festival near Kibbutz Re’im in southern Israel along the Gaza border, where a UN mission said it found credible reports of sexual violence against some of the festival-goers and other Israeli victims of the day’s attacks.

In terms of the UN mission report on sexual violence in Israel and the occupied West Bank, released Monday, the expert team that made a two-week visit from 29 January to 14 February, described “a pattern of victims, mostly women, found fully or partially naked, bound, and shot across multiple locations” in the wake of the 7 October Hamas attack. 

The best evidence of the assaults emerged from victims found around the site of the all-night Nova music festival close to the border, which was overwhelmed early Saturday morning by swarms of Hamas-led fighters; along a major regional road, Route 232, by which festival goers tried to escape, and at Kibbutz Re’im, stated the report of the expert team, led by UN Under-Secretary General and Special Representative on Sexual Violence in Conflict, Pramila Patten. 

With respect to the 253 Israeli and foreign hostages initially taken to Gaza, some of whom have since been released, the mission team found “clear and convincing information that some have been subjected to various forms of conflict-related sexual violence including rape and sexualised torture and sexualised cruel, inhuman and degrading treatment and it also has reasonable grounds to believe that such violence may be ongoing.”

In visits to the West Bank, the UN team also interviewed representatives of the governing Palestinian Authority, as well as Palestinian civil society and several detainees.

“Stakeholders raised concerns about cruel, inhuman and degrading treatment of Palestinians in detention, including the increased use of various forms of sexual violence, namely invasive body searches; threats of rape; and prolonged forced nudity,” the team stated.  

Other UN entities are now investigating those allegations further, it said, adding that “since 7 October 2023, the detaining authorities have severely limited the access of independent humanitarian bodies to detention facilities to monitor the conditions of detention and address any abuses.”  

‘Limited survivor and witness testimony due to large number of casualties

In terms of the 7 October violence, the expert team that visited Israel also cited “credible” witness testimony and digital phone or camera evidence for some of the rape incidents, including at Kibbutz Re’im and along Route 232. 

The team acknowledged, however, that there was  “limited survivor and witness testimony … due to the large number of casualties and dispersed crime scenes in the context of persistent hostilities … the prioritisation of rescue operations and the recovery, identification, and burial of the deceased in accordance with religious practices, over the collection of forensic evidence. 

“Further, a significant number of the recovered bodies had suffered destructive burn damage, which made the identification of potential crimes of sexual violence impossible.”

Key findings included: 

  • “At the Nova music festival and its surroundings, there are reasonable grounds to believe that multiple incidents of sexual violence took place with victims being subjected to rape and/or gang rape and then killed or killed while being raped. Credible sources described finding five murdered individuals, mostly women, whose bodies were naked from their waist down – and some totally naked – tied with their hands behind their backs, many of whom were shot in the head.   
  • “On Road 232, credible information based on witness accounts describe an incident of the rape of two women by armed elements… The mission team also found a pattern of bound naked or partially naked bodies from the waist down, in some cases tied to structures including trees and poles, along Road 232. 

In the case of several other border communities, the team said that while it could not verify sexual violence reports, while conceding that “available circumstantial evidence may be indicative of some forms of sexual violence.” 

It said “female victims were found fully or partially naked to the waist down with their hands tied behind their backs and shot,” in the case of Kibbutz Kfar Aza for instance, suggesting  “potential sexualised torture”. 

Hamas denied allegations, Israel welcomed UN report 

Hamas leaders have as previously denied the rape allegations, while the UN report said that it was impossible to pinpoint who was responsible for individual attacks given the diversity of individuals and armed groups that crossed into Israel from Gaza on the day of the attacks.  Israel’s Foreign Ministry welcomed the report for recognising “that the crimes … point to a pattern of rape, torture and sexual abuse.” 

However, the haste and chaos of the Israeli rescue efforts, the natural reluctance of survivors to come forward, and the deep well of Israeli mistrust of UN institutions in the wake of the 7 October Hamas attacks, were all noted as factors impeding the team’s enquiry. 

“Overall, the mission team is of the view that the true prevalence of sexual violence during the 7 October attacks and their aftermath may take months or years to emerge and may never be fully known,” said the report.

Image Credits: Times of Israel , WHO .

The European Parliament is to vote on a regulation to allow compulsory licencing during crises.

The European Parliament has been challenged to amend a proposed law to enable  countries outside the European Union (EU) to benefit from medical products produced under compulsory licences during crises.

The proposed regulation aims to ensure that, “during specific crises or emergencies”, the EU can issue a compulsory licence to enable the production of certain products – such as vaccines and medicines during a pandemic.

A compulsory licence gives governments the power to allow a third party to use a patent without the authorisation of the patent-holder, subject to certain conditions. 

“Compulsory licensing can therefore complement current EU efforts to improve its resilience to crises,” according to the EU.

But the draft regulation currently prohibits the export of any products produced under compulsory licences outside the EU.

On Tuesday, a group of over 70 influential civil society organisations and academics wrote a letter to the European Parliament challenging them to “support crucial amendments allowing the export of medical tools to third countries in the proposed Union Compulsory License”.

“The COVID-19 pandemic has made clear that major health emergencies need to be addressed at local, national, regional and global level and showcased that the EU’s advanced industrial capacity can be used to help protect EU citizens while also aiding and supplying non-EU countries, aligning with the principle that “No one is safe until everyone is safe”,” the letter notes.

“It is therefore disheartening to note that, when preparing for the next crisis, the EU risks turning its back on the rest of the world, including non-EU countries in Europe, with this compulsory licence proposal,” it adds.

EU harmonisation

Impetus for the new regulation stems from the fact that there is “no EU-wide harmonisation of compulsory licensing for the domestic market”, according to the EU, which adds that the new regulation has two main objectives.

“First, it aims to enable the EU to rely on compulsory licensing in the context of the EU crisis instruments. Second, it introduces an efficient compulsory licensing scheme, with appropriate features, to allow a swift and appropriate response to crises, with a functioning internal market, guaranteeing the supply and the free movement of crisis-critical products subject to compulsory licencing in the internal market.”

The letter’s signatories, including Médecins Sans Frontières, Health Action International (HAI) and Oxfam, state that they support EU compulsory licences as they have “the potential to foster a more effective response to public health challenges”.

But by prohibiting exports, the current draft – which has been put forward for a plenary vote of the European Parliament – goes against flexibilities enshrined in the World Trade Organization (WTO) Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS Agreement), according to the letter.

“This limitation is problematic, especially considering the use of a Union compulsory license would likely be triggered by situations that would affect not only EU countries but also countries outside of the EU, either in the region or globally,” they add.

Pandemics ‘don’t respect borders’

Making exports available under an EU compulsory licence “is not just a matter of international solidarity but is also in the EU’s interest” as it could “help in controlling potential outbreaks and emergencies that could spill over into the EU, allowing EU-based manufacturers to respond promptly to the needs of non-EU countries”.

“This vote is important for a number of reasons,” according to HAI Senior Policy Advisor Jaume Vidal.

“Embracing TRIPS flexibilities is, of course, a welcome step, but the current proposal risks becoming an ‘EU First’ response when it comes to pandemics and health emergencies, reminiscent of the inequities seen during the COVID-19 pandemic.

“Secondly, at a time when countries are negotiating a pandemic accord, a restrictive use of the proposed Union compulsory license that would limit exports would be sending an ominous message to negotiators. Finally, in times of greatest need, the EU would do well to remember that pandemics don’t respect borders or blocs,  and that no one is safe, until everyone is safe.”

Image Credits: Thijs ter Haar.

Charles Akim, a refugee from Sudan living in nothern Kenya, gets high blood pressure medication at Kenya’s Natukobenyo Health Center, as a result of a partnership between UNHCR, the Kenya government, Novo Nordisk Foundation, and others.

COPENHAGEN –  In Lebanon, international donors are supporting a network of public primary health care centers to test for diabetes and other noncommunicable diseases (NCDs), offering treatment equally to Lebanese nationals and Syrian refugees who are unlikely to return anytime soon to their war-torn homeland. 

In Kenya, a new national insurance law aims to make health insurance mandatory and accessible both to unemployed Kenyans as well as to the estimated 625,000 refugees that have been living in the country for 30 years or more. And a much-touted “Shirika” initiative aims to integrate refugee communities into the health workforce, as well as the broader economy. 

In both Moldova and Jordan, refugees fleeing war-torn Ukraine and Syria were immediately brought into the national health systems of their respective host countries at the height of the crisis.  That allowed international aid to be targeted to supporting refugee’s direct medical costs and even expanding national health system capacity, rather than building up a parallel system for the refugee communities.   

As humanitarian crises become more complex and more protracted, extending not years but decades, host governments, as well as United Nations aid agencies and major donor groups, are shifting tactics in an effort to extend to refugees a more holistic range of health services. The effort is particularly relevant when it comes to NCDs, which are often more expensive to diagnose and treat. And such services are not always widely available yet in many low- and middle-income countries that also host tens of millions of the world’s refugees. 

As such, policies and funding plans that simultaneously bolster NCD services for refugees as well as in national health services available to all citizens, may be particularly effective in closing multiple gaps simultaneously. 

The issue of integration was a key theme on the closing day of a three day meeting in Copenhagen on Noncommunicable diseases in Humanitarian Settings; Building Resilient Health Systems, co-organized by the World Health Organization (WHO) and UNHCR, the UN refugee agency.

‘Converging efforts’ is key, says WHO’s Santino Severoni (centre); on left Allen Maina (UNHCR) and on right, Waheed Arian, British radiologist and Afghan refugee.

“It’s paramount when you start a humanitarian response to look at the end system setting for the long term answers,” said WHO’s Director of Health and Migration, Dr. Santino Severoni, speaking Thursday in the closing hours of the event. 

“We see that all in those countries where there is a political commitment, where the political sensitivities about refugees have been diffused and the country is moving on with a rational approach, what is important is to provide support in order to converge efforts, expanding domestic capacity to finance access.  

“Every time we keep the situation in a protracted emergency. Every time we keep funding operations, not directly funding the country’s financial capacity, we are actually postponing the capacity of the country to be more effective.”

Extending Kenya’s social health insurance system to refugees means better NCD coverage

Elizabeth Onyango, Kenya Ministry of Health: Shirika means refugee inclusion, it is also a Swahili word that means coming together.

In Kenya, such an approach has led the government to extend the benefits of a new social health insurance fund intended to cover jobless Kenyan citizens to the country’s 625,000 refugees, who hail mainly from Somalia and Uganda, as well as South Sudan.

After overcoming several court challenges, this year’s plan rollout will extend coverage to tens of thousands of refugees living for decades in the Dadaab and Kakuma camps in the country’s remote northern and northwest regions. It also coincides with the government’s launch of the Shirika Plan, which calls for transitioning the sprawling camps into more open settlements.

“Shirika is an acronym which means social, economic hubs for integrated refugee inclusion,” said Elizabeth Onyango, who heads NCD Prevention and Control at the Kenyan Ministry of Health. “It also is a Swahili word that means coming together.

“So what does the government of Kenya envision? It envisions a situation where the refugee and host communities get together; they can work, play, and even love together. It is multi-agency and multi-sector” – including the health sector as part of the coordinating secretariat.

“For health, the Shirika plan wants to focus on enhancing access to comprehensive health services, including services for NCDs. Secondly, we also want to focus on building or improving the capacity or human resources to deliver the services, including the refugee and the host population, into the country’s social health insurance funding structure,” she said. “And lastly, we focus on preventing people from promoting health, preventing disease and disease surveillance in these regions.”

Integration of refugees will be enabled by the extension of the new Kenyan Social Health Insurance programme to all of the country’s residents.

The new initiative will ensure that primary health care is “free to anyone in Kenya, including refugees,” said Onyango. At secondary and tertiary levels, refugees will be able to obtain a social insurance card for a nominal payment on the same basis as Kenyan citizens, granting them free access to services.

In terms of health facility infrastructure in and around refugee communities, the emerging model is a hybrid with UNHCR, Kenyan county governments and NGOs working in partnership to ensure that health facilities in refugee communities can “provide a wide range of services from preventive promotive of primary health care all the way to tertiary and tertiary care,” Onyango said.

Refugees as part of the health workforce solution 

Charles, a Congolese refugee living in Nyankanda refugee camp in Burundi. He was diagnosed wih high blood pressure in 2017, and now works as a community health worker for the newly established NCD clinic.

Experts have applauded another critical element of the Kenyan plan: capacity-building in the refugee communities – to train a new generation of health workers.

This shifts refugees from being victims and recipients of aid from their host country to being an integral part of the solution. And it addresses the common problem of health worker migration from rural areas, where the most prominent camps are located, to the cities.

“We want to support [refugee] students with scholarships so they can get into medical training colleges,” said Onyango.

“Because one of the things we suffer is the retention of health worker staff; most staff are from other regions. Conversely, if more refugees from the far-flung camps are educated as health workers, she said it’s more likely they’d be willing to return to work in their home communities. She added that bolstering local capacity can help ensure that a full spectrum of NCD services are available in the communities.

“We want to ensure that we have the specialists who can go and mentor the healthcare workers, and at the same time, support groups established by people with lived experience, who can empower people to take charge of their health and ensure better management of their conditions,” she said.

Jordan – health enabling policies and programmes for everyone   

Dr Anas Almohtaseb director of the NCD Directorate in Jordan’s Ministry of Health (left) with Elizabeth Onyango, Kenyan Ministry of Health.

Jordan, host to one of the largest refugee populations in the world, is another country that has prioritised the integration of refugee health into the mainstream health services of the country.  

The country of 11 million people hosts nearly 760,000 refugees and asylum seekers registered with UNHCR. These are mostly Syrians who fled the country since the beginning of the civil war in 2011, but also Iraqi, Yemeni and Sudanese.  And that is not including some 2.3 million Palestinian refugees from the 1948 and 1967 Arab-Israeli wars, who hold Jordanian citizenship but are also registered with the UN refugee agency for Palestinians, UNRWA.  

While there are some health clinics run by UNHCR, UNRWA or affiliated charities, most are served in Jordan’s national system “available to all registered refugees from all nationalities at the non-insured Jordanian rate at public health centres and governmental hospitals”, according to UNHCR. 

“When the Syrian refugee crisis came, and they are our neighbors by the way, the services were provided free of charge for several years,” said Dr Anas Almohtaseb director of the NCD Directorate in Jordan’s Ministry of Health, speaking at the conference, which was co-sponsored by the Hasemite Kingdom, as well as Kenya and Denmark. 

Particularly in terms of NCD-related policies, many government initiatives “related to strengthening the healthcare system, will also strengthen the services provided for refugees,” Almohtaseb stressed, and vice versa. 

As an example, he cited tobacco cessation clinics – which are free and available to everyone, regardless of nationality.  Similarly, in terms of nutrition, Jordanian government plans to supplement basic goods like flour with critical vitamins would benefit the micronutrient status of everyone.   

Jordan also is in the process of updating its guidelines on cardiovascular disease prevention, diagnosis and care to align with the WHO HEARTS protocol, released in 2020. 

“Once we have these unified guidelines, this will help improve the services for every patient, whatever his nationality, said Almohtaseb. “And also we have the implementation of community engagement programmes, such as mental health care clinics, which will be inclusive for the whole population,” he said. 

Finally, digitisation of healthcare services, including better tracking of patients’ diagnoses and treatment, can help improve NCD coverage for refugees, who may be more mobile as they seek work and better living conditions, he pointed out. 

“Ultimately, the refugees affect the whole healthcare system. And for this reason, while NGOs are very important, we have to also be dependent on the public health system – that is crucial to the sustainability of the healthcare system in Jordan.”

New direction for the international health and development community 

Bent Lautrup-Nielsen, head of global advocacy for the World Diabetes Foundation (WDF).
Bent Lautrup-Nielsen, head of global advocacy for the World Diabetes Foundation (WDF).

Strategies that advance the integration of refugee health services with national health systems of host governments represent a “significant improvement” to the traditional approach to health emergencies, said Bent Lautrup-Nielsen, head of global advocacy for the World Diabetes Foundation (WDF).

“This is relatively new to the international health and development community,” Lautrup-Nielsen observed, noting that historically, institutional and funding drivers tended to foster more siloed approaches.

“For many years, the international system of humanitarian response has had its own mechanisms of funding – for example, through appeals by UNHCR, the Red Cross and many others,” and that led to focused emergency health efforts, more siloed approaches, he observes.

Over a decade ago, however, some organisations, including the World Diabetes Foundation, began to see that refugee health issues, with all of the urgency those often implied, could also be an essential entry point for boosting capacity for sorely needed NCD services in affected host countries.

“What we’re saying is that if you’ve got a refugee situation, then the donors should target the whole NCD population – not only refugees but also the host communities. If you start distinguishing between the refugee population and the local population, you risk creating uneven health access and inequities.”

In Lebanon – the refugee crisis led to new primary healthcare investments

Lautrup-Nielsen cites the Foundation’s experience supporting refugees in Lebanon, who fled to the country in the first phases of the Syrian civil war, as one example.

Public health clinics have traditionally played a relatively minor role in Lebanon’s largely privatised health services. However, these clinics became more critical due to the domestic economic crisis and the refugee inflow.

The new healthcare demands stimulated by the refugee crisis ultimately prompted a group of donor organisations, including WDF, the Danish Red Cross and Novo Nordisk Foundation, to support the expansion of NCD services in over 200 public primary health clinics nationwide, serving refugee and host populations. They are rolling out services for cardiovascular disease, diabetes and other conditions, including mental health.

“Building that as an integrated, basic package that wasn’t there before was a benefit to both Lebanese and refugees living in Lebanon,” Lautrup-Nielsen said.

But he notes that integration cannot be a one-size-fits-all approach. “Of course, there are acute emergencies at times that demand a dedicated humanitarian approach. We have a lot of that right now.

“But that cannot be separated from a long-term perspective,” he added. “And the COVID-19 pandemic crisis, which was considered a health emergency, showed that those who suffer the most are people living with NCDs.

“What came out of COVID was that realisation that you have to build resilient health systems that are meaningful in any context and serve everybody.”

Convergence instead of silos 

“Many [high-income] governments and private sector donors and foundations have willingly supported dedicated health services in response to humanitarian crises and emergencies – and for good reason. But this can also create imbalances or a lack of equity in a protracted situation.”

The inequities may also go both ways. In some low-income host countries, UNHCR-provided health services in refugee camps might even be regarded as “better” than what might be available in the local communities, Lautrup-Nielsen pointed out.

“But governments also wish to build equitable health systems, whether for refugees or local communities.

“Amongst the more than 150 countries represented at the conference, many are hosting refugees, and they are also appealing for a balanced international system, combining humanitarian response support in acute emergencies with protracted, long-term national health system strengthening.

“At the same time, most premature deaths from NCDs, before the age of 70, now occur in low- and middle-income countries of Asia, the Americas, the Middle East and Africa – and the disease burden is huge and growing fast.

“Five or ten years ago, this conference probably would not have been possible. But the thinking has matured a lot due to COVID and other things, not the least, because of the NCD agenda,” said Lautrup-Nielsen.

“To put things in a positive light, we are seeing a convergence within the health and development space and with other spaces like humanitarian response.”

Image Credits: UNHCR/Sala Lewis, UNHCR/Mia Bulow-Olsen , E. Fletcher/Health Policy Watch , E Fletcher/Health Policy Watch , UNHCR , Jesper Westley.

The sixth UN Environment Assembly was held in Nairobi

The sixth United Nations Environment Assembly (UNAE-6) ended last Friday in Nairobi, Kenya with the adoption of a Ministerial Declaration affirming member states’ commitment to slowing climate change, protecting biodiversity, and creating a pollution-free world.

The assembly, which attracted over 5,600 delegates from 190 countries, also adopted 15 resolutions covering a range of issues including chemicals, waste, metals and minerals and protecting the environment during and after conflicts.

“As governments, we need to push for more and reinvent partnerships with key stakeholders to implement these mandates. We need to continue to partner with civil society, continue to guide and empower our creative youth, and also with the private sector and philanthropies,” said Leila Benali, UNEA-6 President and the Minister of Energy Transition and Sustainable Development of Morocco. 

Benali noted that the resolutions called for enlightened leadership and urged scaling up means of implementation, enhancing national capacity to implement action plans and policies, and strengthening the science-policy interface.

Evidence of the extent of environmental degradation and its impact on individuals keeps rising. Along with updated estimates of air pollution-related deaths at 8.3 million annually, a host of recent studies have also linked excessive levels of air pollution with health issues ranging from increased neo-natal mortality to Alzheimer’s.  Most recently, one Nature study linked spikes in air pollution with increased risk of deaths by suicide. 

Leila Benali, UNEA-6 President and the Minister of Energy Transition and Sustainable Development of Morocco.

A slew of UN reports released during the assembly last week also presented a grim picture of the immediate future. Data from the 2024 Global Resource Outlook warned that without urgent action to reduce global consumption and production, extraction of natural resources could rise by 60 % from 2020 levels. This would worsen climate and pollution impacts, with consequently greater  risks to biodiversity and human health, the report said. 

It also blamed the high levels of material consumption in upper-middle and high-income countries for the problem. The report said that the rich countries use six times more resources and generate 10 times  climate impacts than low-income ones. 

The Global Waste Management Outlook 2024 showed that without a seismic shift away from ‘take-make-dispose’ societies towards circular economy and zero-waste approaches, the world’s waste pile could grow by two-thirds by 2050, and its cost to health, economies and the environment could double.  It reiterated that only a drastic reduction in waste generation will secure a liveable and affordable future, and ways to convert waste into a reusable resource would have to be employed.

Another UNEP report on Used Heavy Duty Vehicles and the Environment launched during a Climate and Clean Air Conference held ahead of UNEA, sounded the alarm on the rise of emissions from these heavy polluters, and their negative climate and health impacts.

Resolutions on improving response

The assembly also held its first Multilateral Environmental Agreements (MEA) Day that was dedicated to the international agreements addressing the most pressing environmental issues. UNEA-6 welcomed youth to host their own environmental summit, which called for greater inter-generational equity.

“The President has gavelled resolutions that address desertification, land restoration and more. We also have a ministerial declaration that affirms the international community’s strong intent to slow climate change, restore nature and land, and create a pollution-free world,” Inger Andersen, UN Evironmental Programme Executive Director, said.

“UNEP will now take forward the responsibilities you have entrusted to us in these new resolutions. In addition to keeping the environment under review. In addition to fulfilling our obligation to serve as an authoritative advocate for action across the triple planetary crisis,” Andersen added.

“In our quest to confront the monumental environmental challenges of our time—climate change, biodiversity loss, and pollution—there is but one path forward: teamwork. We share one Earth, bask under the same sun, and we must recognize that there is no backup plan. There’s no other planet waiting for us to escape to,” said Abdullah Bin Ali Amri, Oman’s chair of the Environment Authority and president-elect of the next UNEA, which will be held in December 2025 in Nairobi.

INB co-chair Precious Matsoso (right) injects some humour into proceedings after two long weeks of negotiations while co-chair Roland Driece looks on.

Text-based negotiations on a pandemic agreement will finally start at the next meeting of the intergovernmental negotiating body (INB) on 18 March, with the draft negotiating text due to be circulated to  World Health Organization (WHO) member states by this Friday, 8 March.

This follows an intense two weeks of the eighth round of INB negotiations, which ended on Friday (1 March) with member states expressing their confidence in the co-chairs and their deputies, who have been marshalling the informal talks so crucial to this process.

The INB has held 385 hours of formal meetings and over 80 hours of informal meetings over the past two years, and member states need to ensure this time was not wasted, co-chair Precious Matsoso told INB members at the close of the body’s eighth meeting last week.

South Africa’s Matsoso, injecting her characteristic good humour into the dry negotiations, closed the meeting with a quote from singer Sister Sledge, reminding member states that “we are family”.

However, like in most families, the INB has plenty of squabbles to iron out ahead of adopting any meaningful agreement.

Conditions for equity

Pakistan representing the Group for Equity at the pandemic agreement negotiations.

Pakistan, on behalf of the Group for Equity, delineated the most important areas for its largely developing country members at the closing session of INB8. These are also the issues over which there is no agreement.

Importantly, they want pathogen access and benefit sharing (PABS) system to “guarantee equitable benefit sharing on an equal footing, prohibiting anonymity to ensure transparency and accountability”.

PABS is one of the biggest sticking points in the negotiations, as previously reported by Health Policy Watch.

They want the agreement to contain “normative” technology transfer provisions in which countries have the right to “request and demand” tech transfer and licensing.

The group also wants country obligations, particularly related to surveillance and prevention, to be “proportionate to the respective capabilities and context”, build capacity in weaker countries and be in line with “the principle of common but differentiated responsibilities (CBDR)”. 

CBDR is commonly used in environmental law and means that countries’ obligations depend on their socio-economic status and historical contribution to environmental problems. 

The Group on Equity also wants “a predictable and sustainable financial mechanism” for pandemic prevention, preparedness and response that is part of the UN and “will ensure that resources are available in a timely and efficient manner, facilitating swift and effective responses to current and future health emergencies. 

Finally, the group wants governance over the agreement to be “designed to maximise participation and ensure accountability to the parties” and for a legally binding agreement that is “applicable and operable for all parties without any barriers”.

The Group for Equity comprises 29 countries representing an interesting alliance of largely African, Latin American and South and South East Asian countries, namely: Argentina, Bangladesh, Botswana, Brazil, China, Colombia, Dominican Republic, Egypt, El Salvador, Eswatini, Ethiopia, Fiji, Guatemala, India, Indonesia, Iran, Kenya, Malaysia, Mexico, Namibia, Pakistan, Palestine, Paraguay, Peru, Philippines,. South Africa, Tanzania, Thailand and Uruguay. 

Ethiopia representing the position of the Africa group during pandemic agreement negotiations.

Ethiopia, on behalf of the 47 African member states plus Egypt, wants a “multilateral pathogen access and benefit-sharing system with clear data governance and accountability for sharing pathogens” and a “dedicated financing mechanism with inclusive governance”.

Wishing for more progress

The European Union, on behalf of its 27 member states, urged negotiators to look at areas of agreement rather than divergence, which “are not insignificant” and provide “room there for a solid basis for continued good work that can get us to a successful outcome already by May”.

However, Germany “had somewhat wished to make more progress” during INB8  in “finding convergence”.  

“Time to come to convergence is extremely short. The text that will be presented next week is going to be crucial for all of us. It has to facilitate a meaningful outcome along the full PPR cycle,” said Germany.

“We also need to continue our discussions on an effective system for pathogen access and benefit sharing (PABS). PABS needs to be implementable. It must not hinder research and access and it needs to ensure reliable benefit-sharing with the necessary broad participation of the private sector.” 

The European Union at INB 8

Stakeholders: In or out?

A bone of contention during the negotiations is how little space civil society organisations (CSO), academics, the private sector and other stakeholders have had to express their views.

The Pandemic Action Network (PAN) organised two civil society sessions during the past INB meeting with the participation of around 100 organisations, many of which appealed for better access to the negotiations.

Last week, STOPAIDS, PAN and a number of other groups wrote a letter to the INB Bureau asking for the “official involvement of CSOs in all remaining negotiations in the INB process for a new pandemic agreement”.

“We demand the same rights accorded to civil society including as allowed during negotiations on (for example) the UNFCCC [UN Framework Convention on Climate Change], and the Convention on Biological Diversity,” they state.

“Not only will access for CSOs be crucial for reasons of transparency and legitimacy, but also because CSOs provide technical expertise and community testimony through briefings for negotiators during the official sessions. A broad range of member states has welcomed contributions from civil society during INB 8 but these have predominantly been made inside events in the margins of the negotiations. It is vital we form part of the process.”

The INB Bureau, in consultation with the WHO Secretariat, will propose a couple of options for the inclusion of stakeholders at the next meeting but Matsoso said that member states had agreed that stakeholders would not be in the room during negotiations. However, there could be regular reportbacks or a session where stakeholders briefed member states about the draft, she added.

Germany stressed that “strengthening our engagement with civil society, stakeholders and experts from all relevant areas is crucial. We look forward to their structured and meaningful inclusion during INB 9”.

A patient with age-related hearing loss (Presbycusis), receiving free treatment from the NGO, All Ears Cambodia.

Over 400 million people with hearing loss could benefit from hearing devices. However, less than 20% of those people actually get hearing aids. 

That’s one of the findings cited in new World Health Organisation guidelines on improving access to hearing care, published Friday, just ahead of World Hearing Day

“Unaddressed hearing loss is a global public health challenge and incurs an estimated cost of over US$ 1 trillion annually. Given the global shortage of ear and hearing care specialists, we have to rethink how we traditionally deliver services,” said Dr Bente Mikkelsen, director of the WHO’s Department for Noncommunicable Diseases.

By 2050, nearly 2.5 billion people are projected to experience a degree of hearing loss, as populations around the world age. More than 700 million will likely require hearing rehabilitation, estimates the WHO.

But nearly 80% of people with disabling hearing loss live in low-income countries – which historically have lacked capacity for providing assistive devices like hearing aids. 

Fighting misconceptions and lack of resources

But addressing hearing loss is not necessarily expensive. An investment of $1.4 per person annually would be sufficient to scale up ear and hearing care services worldwide, WHO said.

To overcome current limitations of capacity, the guidelines encourage more service delivery by non-specialists, based in primary health care settings. 

Debunking misconceptions and stigma around hearing loss is another key aim of the guidelines, created with the support of ATscale Global Partnership for Assistive Technology. 

“Common myths about hearing loss often prevent people from seeking the services they require, even where these services are available,” said Dr Shelly Chadha, technical lead for ear and hearing care at WHO. 

“Any effort to improve hearing care provision through health system strengthening must be accompanied by work to raise awareness within societies and address stigma related to ear and hearing care.”

Image Credits: WHO/Miguel Jeronimo.

WASHINGTON, DC – When US Senator Amy Klobuchar’s father, the late Jim Klobuchar, was diagnosed with Alzheimer’s disease, the noted Minnesota newspaper columnist gradually stopped recognizing her – although he retained “a kind of savoir faire” to the very end with words, jokes and storytelling based on the decades of “lines enmeshed in his memory,” she recalled.  

Senator Amy Klobuchar at an Alzheimer's disease event
Senator Amy Klobuchar (D-MN)

In the United States, one in every three seniors will be diagnosed with Alzheimer’s. The disease affects roughly 55 million people globally and is the seventh leading cause of death. 

“But it’s not just the numbers. It’s the fathers and mothers, it’s the brothers and sisters,” remarked Klobuchar, (D-MN), who recounted the story of her father’s illness at a high-level event here this week, organized by the Davos Alzheimer’s Collaborative (DAC) together with Scientific American. 

The meeting of the collaborative, a Swiss and US-based foundation launched at the World Economic Forum in 2021, brought together some 100 Alzheimer researchers and front-line clinicians as well as policymakers and industry and civil society advocates, to share progress on new innovations in diagnosing and treating the disease – as well as challenges faced in getting those same innovations into healthcare systems globally. 

But the event, co-hosted by Scientific American, also was marked by moments of personal reflections, both comic and tragic. Not only Klochubar, but other speakers in the room referred to their own experiences in dealing with family members with Alzheimer’s disease – what Senator Susan Collins (R-ME) termed “the defining disease” of her generation. 

Joining together across borders and cultures  

Older couple with Alzheimer's disease on a bench
Alzheimer’s is a growing issue worldwide as populations age

And while much of the attention around Alzheimer’s so far has been in the United States and other countries of the global north, the disease is a growing problem worldwide, as populations age and people live longer, but not always healthier lives. 

Researchers predict that lower and middle income countries will soon bear the brunt of Alzheimer’s disease – much as they already do with regards to other noncommunicable diseases. 

Worldwide projections of Alzheimer's prevalence
Alzheimer’s disease is projected to affect more than 100 million people globally 2050

And as in all disease research, a global approach can help identify new therapies more effectively and cost-efficiently.

“Rather than succumb to despair, what we’re doing is joining together across borders, cultures, and languages to chart a future for the world of prevention, effective treatment, and one day, a cure,” said Collins, who lost a brother to Alzheimer’s. Along with being vice-chair of the powerful Senate Appropriations Committee, Collins is also founder and co-chair of a Congressional Task Force on Alzheimer’s disease. 

George Vrandenburg davos alzheimer's collaborative
George Vradenburg, founding chairman of the Davos Alzheimer’s Collaborative

I want to speak on behalf of families…50 million families worldwide are struggling with this disease.” said DAC chairman George Vradenburg, who first launched the initiative in response to a challenge by WEF founder and executive director Klaus Schwab.  He said that DAC was committed to “including researchers, clinicians and families in this fight globally, ensuring that no corner of the world is left untouched by our efforts.” 

Added Collins, “We need a global approach modeled on what we’ve done with AIDS, tuberculosis, and malaria. And we know that that kind of global collaborative approach to bring the research directly to a broader spectrum of countries and communities will remove long standing barriers to care and help us eliminate disparities.” 

“A transformative moment”: Novel diagnostic tests, gene sequencing, and precision medicine

Panelists discuss Alzheimer's disease research
Moderator Jeremy Abbate, VP and publisher of Scientific American with former NIH Director Dr. Elias Zerhouni, University of Washington’s Dr. Suzanne Schindler and Dr. Jeffrey Burns, University of Kansas Medical Center

Early Alzheimer’s disease research was rather akin to “staring up a cliff,” said former US National Institutes of Health (NIH) director Elias Zerhouni, one of the other speakers at the event. Now, however, the world has reached a turning point where, “we can truly have a global approach.”  

Improved genetic sequencing, the advent of digital and biological markers, novel drugs, and a more open mindset to alternative hypotheses have seen Alzheimer’s disease research leap into a new era. 

“We have an explosion of ways to test for Alzheimer’s disease,” remarked Suzanne Schindler, Associate Professor of Neurology at Washington University School of Medicine. Among them are blood tests that can measure up to 5,000 various proteins- a method faster and less invasive than dreaded spinal taps. 

Other panelists shared this optimism, citing the use of amyloid pet-scans and other diagnostics to more accurately assess Alzheimer’s progression in patients.  Genetic sequencing too is cheaper, a marked change since the early days when researchers remained in the dark about the potential genetic drivers of the disease.  

‘More than buildup of amyloid plaques’ 

Alzheimer's disease and tau proteins
One of the causes of Alzheimer’s appears to be the abnormal accumulation of tau proteins in the brain, eventually forming tangles inside neurons, seen here

With these tools comes an understanding that “the disease is more than just about build up [of amyloid plaques],” commented Jeffrey Burns, Professor of Neurology at University of Kansas Medical Center. 

New research into disease risk factors is moving beyond conventional descriptions of amyloid plaques and tau protein pathways to include research into inflammation and lifestyle factors. 

The future of prevention, he speculated, will increasingly lie in more holistic lifestyle approaches undertaken in tandem with medications. “We don’t just give patients with heart disease medication, we tell them to modify their diet, their lifestyle.

“I believe we will prevent the disease,” Burns added. 

Early Alzheimer’s detection remains a missing link

Panelists discuss aging and Alzheimer's disease at an event in DC
Phyllis Ferrell (center left,) Arindam Nandi, and Terry Fulmer discuss the implications of an aging society with Jeremy Abbate.

One major challenge is the need to move new knowledge into hospitals and health clinics; currently it can take as long 17-20 years for innovations to get into clinical practice due to outdated models of care. 

“We are building bullet trains, but running them on the same wooden tracks,” said Dr Phyllis Ferrell, DAC advisor on healthcare systems preparedness. 

Too often, practitioners still take a “wait and see” approach, while symptoms of cognitive impairment go unrecognized or undiagnosed until much later in the disease course. She urged a shift to a more preventative approach with screenings and help manage cognitive symptoms early.

“Why did it take four separate visits to get my dad an inconclusive diagnosis?” Ferrell asked.

“Early detection gives people the time to focus on what matters most to them,” she added. “It provides an opportunity to implement positive lifestyle changes and address risk factors, pursue treatment options and/or enroll in a clinical trial.”

Getting new innovations into practice 

Ferrell also bemoaned the frustration families feel over the lack of access to new diagnostics and therapeutics – in the wake of progress made in research. 

In 2010 the NIH funded Alzheimer’s disease research to the tune of $400 million annually. Fourteen years later, the annual investment is now close to $4 billion, she noted. 

Yet, despite this influx of funding for research, there’s a huge gap emerging in affordable and available drugs. 

“We have innovations that are ready, but are not being used,” she said, adding “Yes, to research, but we need to do things today. Let’s go after clinically ready innovations.”

Staying the course on research 

Senator Susan Collins (R-ME)- a leading champion in Congress for Alzheimer’s disease research.

At the same time, more research into the disease remains critical to find even more effective preventive strategies as well as possible cures.  This means building specimen repositories across the country, performing skin tests for early detection of Alzheimer-related protein abnormalities traditionally only detectable from brain biopsies, and other research. 

Zerhouni called it breaking the “taboo of the brain” – an area of human physiology where research was historically inadequate. “This is a frontier that has to be broken.”

For many years, such research was impeded by social taboos around Alzheimer’s disease. “People used to just call it senility,” said Collins, who has been the leading champion of Alzheimer’s research and action on Capitol Hill for over a decade. 

Collins last year initiated bipartisan legislation in the US Congress to help maintain the funding for Alzheimer’s research, as well as supporting initiatives to bring down the cost of new drugs in the US for Alzheimer patients. At $345 million billion a year, the disease is currently the most costly disease in the nation to treat, she says. 

A global economic burden 

Globally, Alzheimer’s disease also presents an enormous economic burden – costing the world’s economies some $1.3 trillion, in terms of medications as well as care – much of it unpaid, noted Population Council economist Arindam Nandi.  

In the past, economic data came mostly from high income countries, Now, data is available from lower and middle-income countries like India and China. 

“These data depict a worrying trend; the percentage of unpaid care is higher in these countries, meaning that caregivers are not able to get other jobs, decreasing economic output,’ he said. 

 

Nandi also mentioned that predictive models forecast the shifting burden of disease from high income countries to middle and low income countries. “We don’t know how these populations will fare.” Investments in these countries are needed to strengthen their overall public health measures. 

Meanwhile, the US and high income countries can learn from the experiences of low and middle income countries, which often are first to devise lower-costs methods for detecting and treating diseases.

DAC, for instance, funded an Early Detection Flagship program involving six countries, including the US, Scotland, Jamaica, Japan, Mexico and Brazil. They participated in a pilot designed to increase access to early detection and diagnosis of the disease through the use of innovative new screening tools. 

“One of the things I loved [about the Early Detection program]  was watching the US and high resource countries learn from LMICs,” Ferrell observed. “As the founder of the Brain and Mind Institute of Aga Khan University once said, ‘when it comes to Alzheimer’s disease we are all developing nations.’ “

Image Credits: Getty Images, Pixelmestudio/DAC, National Institutes on Aging , UCLA , S. Samantaroy/HPW.

Member states have been slow to implement WHO policies to address obesity, including taxes on sugary drinks and restrictions on marketing junk food to kids

The private sector “must be held accountable for the health impacts of their products”, warned the head of the World Health Organization (WHO) amid news that obesity has quadrupled in children and more than doubled in adults since 1990.

Dr Tedros Adhanom Ghebreyesus was speaking ahead of the release of a huge global obesity study involving over 220 million people from more than 190 countries published in The Lancet on Friday. 

“Getting back on track to meet the global targets for curbing obesity will take the work of governments and communities, supported by evidence-based policies from WHO and national public health agencies,” added Tedros.

Countries with highest obesity rates 2022

Tonga, American Samoa and Nauru have the world’s highest obesity rates, affecting some 60% of their adult populations. 

“The largest increases are in some countries in the Pacific, the Caribbean, the Middle East and North Africa, and some of the newly high income countries like Chile,” said senior author Professor Majid Ezzati, of Imperial College in London, at a media briefing on Thursday.

The US is the only high-income country that features in the ten worst affected countries – with the 10th highest obesity rate in men. Some 43.8% of US women and 41.6% of men were living with obesity in 2022.

Meanwhile, obesity is slowing in a handful of west European countries – notably Spain and France. However, countries with the lowest obesity rates are generally low-income countries with high rates of under-nutrition, with a few exceptions such as Japan and Viet Nam.

Countries with lowest obesity rates 2022

Huge rise in child obesity

In 1990, around 31 million children (2,1% of boys and 1.7% of girls) were obese. But 32 years later, there had been a fourfold increase in both boys (to 9,3%) and girls (6.9%) affecting almost 160 million children.

“It is very concerning that the epidemic of obesity that was evident amongst adults in much of the world in 1990 is now mirrored in school-aged children and adolescents,” said Ezzati.

Professor Majid Ezzati, of Imperial College in London

While boys are more likely to be obese than girls globally, this trend is reversed in adulthood with many more women than men living with obesity. 

But men seem to be catching up. Obesity in men has nearly tripled over the past 32 years, while it has doubled in women. 

“Different forms of malnutrition still coexist in many countries,” said Dr Francesco Branca, WHO Director of Nutrition and Food Safety and one of the co-authors of the study. 

“The child who was undernourished in the first years of life can later become overweight or obese as an adolescent or an adult. Undernutrition and obesity are two faces of the same problem, which is the lack of access to healthy diets.”

Greater risk of NCDs

Undernourished people are more susceptible to infectious diseases, while obesity can lead to Type 2 diabetes, heart disease, certain cancers and affect bone health and reproduction, added Branca, who was also addressing the briefing.

“The increase in the double burden of malnutrition is a result of a transition in food system and lifestyle that has not been governed by public health policies,” he added.

However, despite WHO guidelines on what countries can do to address the massive rise in consumption of energy-dense ultra-processed food, adoption by member states has been slow.

At the World Health Assembly in 2022, member states adopted the WHO Acceleration plan to stop obesity. Core interventions include promoting breastfeeding,  regulating marketing of ultra-processed food and drinks to kids, taxation and warning labels on foods high in fats, salt and sugar.

Dr Francesco Branca, WHO Director of Nutrition and Food Safety

“The reason why the epidemic has progressed so quickly is because the policy action has not been incisive enough,” said Branca, adding that countries had focused on behaviour change rather than “structural elements, which is the policies around food environment”. 

However, he added that more countries were taxing sugary drinks, although “not many countries have done it for sufficiently long time and in ways that are demonstrated to be most effective”. 

“Very few countries put a restriction on marketing food to children. We know that some South American countries are taking that action much more effectively, and we look forward seeing the impact of those policies,[as well as] having warning signs on the processed food which would really discourage people from f buying products which are high in salt, sugar and fat”.

If these policies were implemented, this would likely lead to food and beverage companies reformulating their products to reduce harmful ingredients, he added.

Role of new weight-loss pills?

Branca said that the WHO was currently looking at the efficacy of the new drugs called glucagon-like peptide 1 (GLP-1) agonists – such as Wegovy, Ozempic – which have been approved as weight-loss medication in some countries.

“The solution is still is a transformation of the food system and in the environment such obesity can be prevented,” Branca stressed.

However, the GLP-1 drugs could provide a tool to help those that already live with obesity, as long as they were integrated into a primary healthcare package to manage obesity that included guidance on exercise and diet.

The new study was conducted by the NCD Risk Factor Collaboration (NCD-RisC), in collaboration with the World Health Organization (WHO), and involved over 1,500 researchers. They based their analysis on body mass index (BMI). Adults with BMI 30kg/m2 and over were classified as obese and underweight if their BMI was below 18.5kg/m2. For children, BMI was adjusted according to age. .

Image Credits: World Obesity Federation.